Temozolomide (TMZ) is used to treat primary brain tumors and non-small cell lung cancer (NSCLC) brain metastases, yet therapeutic efficacy is often limited by the DNA repair enzyme O<sup>6</sup>-methylguanine-DNA methyltransferase (MGMT). This evidence concerns the gene LIG4 and non-small cell lung carcinoma.